What Ahammune Biosciences does
Founded in 2016, Ahammune Biosciences operates in Health Tech industry. Initially concentrating on therapeutic solutions for vitiligo, the company has expanded its research and development efforts to include treatments for other dermatological conditions. The companys offerings have broadened through collaborations with leading research institutions, enhancing their scientific capabilities in dermatological innovations. Competing with companies such as Vyome Therapeutics and Invictus Oncology.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Ahammune Biosciences yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.